Loading...
Docoh

Concert Pharmaceuticals (CNCE)

News

From Benzinga Pro
The Analyst Says 'Impressive Phase 3 Data Highlight Best-In-Class Opportunity' For Concert Pharma
23 May 22
Analyst Color, Biotech, News, Penny Stocks, Health Care, Reiteration, Analyst Ratings, General
Concert Pharma's CTP-543 Shows Clinical Efficacy Against Scalp Hair Loss
23 May 22
Biotech, News, Penny Stocks, Health Care, Movers, Trading Ideas, General
Mizuho Sees Relief For This Small-Cap Stock After Patent Legal Overhang Lifted
13 May 22
Analyst Color, Biotech, News, Penny Stocks, Health Care, Reiteration, Legal, Analyst Ratings, Movers, Trading Ideas, General
90 Biggest Movers From Yesterday
13 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
12 Health Care Stocks Moving In Thursday's Intraday Session
12 May 22
Intraday Update, Markets, Movers
58 Stocks Moving In Thursday's Mid-Day Session
12 May 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
28 Stocks Moving in Thursday's Pre-Market Session
12 May 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 89.7% to $0.1480 in pre-market trading after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Concert Pharma: Q1 Earnings Insights
5 May 22
Earnings, News
Concert Pharma (NASDAQ:CNCE) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Concert Pharmaceuticals Q1 EPS $(1.03) Misses $(0.91) Estimate
5 May 22
Earnings, News
Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly losses of $(1.03) per share which missed the analyst consensus estimate of $(0.91) by 13.19 percent. This is a 53.73 percent decrease over losses of $(0.67) per
Earnings Scheduled For May 5, 2022
5 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Earnings Outlook For Concert Pharmaceuticals
4 May 22
Earnings
Concert Pharmaceuticals (NASDAQ:CNCE) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Concert Pharmaceuticals will report an earnings per share (EPS) of $-0.91.
Concert Pharma Earnings Conference Call Is Coming Up, Here's What You Need To Know
29 Apr 22
Earnings
Concert Pharma (NASDAQ:CNCE) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Concert Pharma (CNCE) Conference Call Follow this link to access the live webcast.
Big Pharma's Sanofi Enters Licencing Agreement With Private Psychedelics Company Terran
25 Apr 22
Biotech, Cannabis, News, Psychedelics, Health Care, Markets, General
Terran Biosciences is slowly but surely finding its place in the psychedelics industry.
Concert Pharmaceuticals Earnings Perspective: Return On Capital Employed
8 Mar 22
Earnings
Benzinga Pro data, Concert Pharmaceuticals (NASDAQ:CNCE) reported Q4 sales of $13.00 thousand. Earnings fell to a loss of $36.13 million, resulting in a 35.43% decrease from last quarter.
Recap: Concert Pharmaceuticals Q4 Earnings
3 Mar 22
Earnings, News
Concert Pharmaceuticals (NASDAQ:CNCE) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Concert Pharmaceuticals Q4 EPS $(1.01) Misses $(0.73) Estimate, Sales $13.00K Up From $7.00K YoY
3 Mar 22
Earnings, News
Concert Pharmaceuticals (NASDAQ:CNCE) reported quarterly losses of $(1.01) per share which missed the analyst consensus estimate of $(0.73) by 38.36 percent. This is a 46.38 percent decrease over losses of $(0.69) per
Earnings Scheduled For March 3, 2022
3 Mar 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.
A Preview Of Concert Pharmaceuticals's Earnings
2 Mar 22
Earnings
Concert Pharmaceuticals (NASDAQ:CNCE) is set to give its latest quarterly earnings report on Thursday, 2022-03-03. Here's what investors need to know before the announcement. Analysts estimate that Concert Pharmaceuticals will report an earnings per share (EPS) of $-0.73.